View All In Series
Published on December 17, 2020
Experts Discuss Immunotherapies, Clinical Trials & Individualized Treatment
What are the key takeaways in myeloproliferative neoplasm (MPN) research from ASH 2020? How have immunotherapy treatments advanced? Are there any promising new clinical trials? And finally, among so many options for MPN treatment, how can you and your care team create an individualized treatment plan that is right for you?
Hear four of the world's leading MPN experts answer these questions and more with host and MPN patient advocate Ruth Fein. The panel includes Dr. Srdan Verstovsek, MD, Ph.D., of MD Anderson Cancer Center, Dr. Brady Lee Stein, MD, of Northwestern’s Lurie Cancer Center, Dr. Olatoyosi Odenike, MD, of the University of Chicago Medicine and Dr. Angela Fleischman, MD, Ph.D., of UC Irvine Health. They will also cover topics including the potential for universal donors and why MPN patients should receive a COVID-19 vaccine.
This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.